Epilepsy Research
Volume 29, Issue 2 , Pages 147-154 , January 1998

Myoclonus and epilepsy in childhood: A review of treatment with valproate, ethosuximide, lamotrigine and zonisamide

Received 7 April 1997 ,Revised 10 September 1997 ,Accepted 14 September 1997.

References 

  1. Aicardi J. Myoclonic epilepsies of infancy and early childhood. In: Aicardi J, editor. Epilepsy in Children. New York:Raven Press, 1994:67–79.
  2. Appleton RE, PanayIotopoulos CP, Acombe BA, Beirne M. Eyelid myoclonia with typical absences: an epilepsy syndrome. J Neurol Neurosurg Psychiatry. 1993;56:1312–1316
  3. Asconapé J, Penry JK. Some clinical and EEG aspects of benign juvenile myoclonic epilepsy. Epilepsia. 1984;25:108–114
  4. Bacia T. Lamotrigine (Lamictal) as add-on therapy in chronic, intractable severe forms of epilepsy. Epilepsia. 1995;36(Suppl 3):S115
  5. Battino D, Buti D, Estienne M, Faxio A, Giranata T, Pisani F, et al. Lamotrigine in resistant childhood epilepsy. Neuropediatrics. 1993;24:332–336
  6. Besag F. Lamotrigine: pediatric experience. In: Richens A, editor. International Clinical Practice Series, Clinical Update on Lamotrigine: A Novel Antiepileptic Agent. Royal Tunbridge Wells:Wells Medical, 1992:53–60.
  7. Besag FMC, Wallace SJ, Dulac O, Alving J, Spencer SC, Hosking G. Lamotrigine in the treatment of epilepsy in childhood. J Pediatr. 1995;127:991–997
  8. Buchanan N. The use of lamotrigine in juvenile myoclonic epilepsy. Seizure. 1996;5:149–151
  9. Christe W, Jacob R, Janz D. Juvenile myoclonic epilepsy: response to valproate monotherapy in 27 previously untreated patients. Epilepsia. 1995;36(Suppl 3):S65
  10. Coppola G, Bove RM, Nazzaro A, Pascotto A. Lamotrigine in children with refractory epilepsy: an open trial. Epilepsia. 1995;36(Suppl 3):S111–112
  11. Covanis A, Gupta AK, Jeavons PM. Sodium valproate: monotherapy and polytherapy. Epilepsia. 1982;23:693–720
  12. Covanis A, Skiadas K, Loli N, Ioannidou A, Lada C, Theodorou V. Eyelid myoclonia with absence. Epilepsia. 1994;35(Suppl 7):S13
  13. Delgado-Escueta AV, Enrile-Bascal F. Juvenile myoclonic epilepsy of Janz. Neurology. 1984;34:285–294
  14. Doose H. Myoclonic astatic epilepsy of early childhood. In: Roger J, Bureau, M, Dravet Ch, Dreifuss FE, Perret A, Wolf P, editors. Epileptic Syndromes in Infancy, Childhood and Adolescence. 2nd ed. London:Libbey, 1992:103–114.
  15. Dravet Ch, Bureau M, Guerrini R, Giraud N, Roger J. Severe myoclonic epilepsy in infants. In: Roger J, Bureau M, Dravet Ch, Dreifuss FE, Perret A, Wolf P, editors. Epileptic Syndromes in Infancy, Childhood andAdolescence. 2nd ed. London:Libbey, 1992:75–88.
  16. Dravet Ch, Bureau M, Roger J. Benign myoclonic epilepsy in infants. In: Roger J, Bureau M, Dravet Ch, Dreifuss FE, Perret A, Wolf P, editors. Epileptic Syndromes in Infancy, Childhood and Adolescence. 2nd ed. London:Libbey, 1992:67–74.
  17. Dulac O, Stern D, Rey E, Perret A, Arthuis M. Sodium valproate monotherapy in childhood epilepsy. Brain Dev. 1986;8:47–52
  18. Dulac O, Withers RM, Yuen AWC. Add-on lamotrigine in pediatric patients with treatment-resistant epilepsy. Epilepsia. 1991;32(Suppl 1):S95
  19. Farrell K. The Canadian Pediatric Lamotrigine Collaborative Group, Canadian retrospective study of lamotrigine in intractable childhood epilepsy. Epilepsia. 1996;37(Suppl 4):S65
  20. Ferrie CD, Agathonikou A, Parker A, Robinson RO, Panayiotopoulos CP. The spectrum of childhood epilepsies with eyelid myoclonia. In: Duncan JS, Panayiotopoulos CP, editors. Eyelid Myoclonia with Absences. London:Libbey, 1996:39–48.
  21. Fontana E, Zollini E, Zoccante L, Capellaro O, Franco A, Dalla Bernardina B. Lamotrigine treatment in 50 cases of childhood epilepsy. Epilepsia. 1996;27(Suppl 4):S65
  22. Genton P, Dravet Ch. Treatment of epilepsies with myoclonia. In: Shorvon S, Dreifuss F, Fish D, Thomas D, editors. The Treatment of Epilepsy. Oxford:Blackwell, 1996:247–257.
  23. Gericke CA, Hirsch E, de Saint-Martin A, Picard F, Strumia S, Dutoya V, et al. Efficacy of lamotrigine in idiopathic generalized epilepsy: a video-EEG controlled, open study. Epilepsia. 1996;37(Suppl 5):S165
  24. Gibbs J, Appleton RE, Rosenbloom L, Yuen WC. Lamotrigine for intractable childhood epilepsy: a preliminary communication. Dev Med Child Neurol. 1992;34:369–371
  25. Gusev E, Petroukhin A, Bourd G, Medvedev M, Mukhin K. Lamotrigine (Lamictal) in treatment of resistant epilepsy in children. Epilepsia. 1996;37(Suppl 4):S67
  26. Hirsch E, Dutoya V, Strumia S, Marescaux C. Lamotrigine and generalised epilepsy syndromes. Epilepsia. 1995;36(Suppl 3):S112
  27. Hosking G, Spencer S. Lamotrigine as add-on therapy in pediatric patients with treatment-resistant epilepsy. Epilepsia. 1993;34(Suppl 2):S66
  28. Hurst DL. Expanded therapeutic range of valproate. Pediatr Neurol. 1987;3:342–344
  29. Jeavons PM. Nosological problems of myoclonic epilepsies in childhood and adolescence. Dev Med Child Neurol. 1977;19:3–8
  30. Jeavons PM, Clark ME, Maheshwari MC. Treatment of the generalised epilepsies of childhood and adolescence with sodium valproate (Epilim). Dev Med Child Neurol. 1977;19:9–25
  31. Kyllerman M, Ben-Menachem E. Zonisamide for progressive myoclonus epilepsy: Long term observations in 7 patients. In press.
  32. Manonmani V, Wallace SJ. Epilepsy with myoclonic absences. Arch Dis Child. 1994;70:288–290
  33. Muszkat M, Rizzutti S, Reis de Campos CJ. Lamotrigine in refractory childhood epilepsy. Epilepsia. 1995;36(Suppl 3):S111
  34. Panayiotopoulos CP, Ferrie CD, Knott C, Robinson RO. Interaction of lamotrigine with sodium valproate. Lancet. 1993;341:445
  35. Richens A, Yuen AWC. Overview of the clinical efficacy of lamotrigine. Epilepsia. 1991;32(Suppl 2):S13–16
  36. Roger J, Genton P, Bureau M, Dravet Ch, Less common epileptic syndromes. In: Wyllie E, editor. The Treatment of Epilepsy: Principles and Practice. Philadelphia:Lea and Febiger, 1993:624–635.
  37. Sander JWAS, Hart YM, Patsalos PN, Duncan JS, Shorvon SD. Lamotrigine and generalised seizures. Epilepsia. 1991;32(Suppl 1):S59
  38. Sander JWAS, Trevisol-Bittencourt PC, Hart YM, Patsalos PN, Shorvon SD. The efficacy and long-term tolerability of lamotrigine in the treatment of severe epilepsy. Epilepsy Res. 1990;7:226–229
  39. Santavuori P, Himberg J-J, Ahola A, Hosking G, Yuen AWC. Lamotrigine therapy in infantile neuronal ceroid-lipofuscinosis. Epilepsia. 1995;36(Suppl 3):S264
  40. Schlumberger E, Chavez F, Palacios L, Rey E, Pajot N, Dulac O. Lamotrigine in treatment of 120 children with epilepsy. Epilepsia. 1994;35:359–367
  41. Serratosa JM, Delgado-Escueta AV. Juvenile myoclonic epilepsy. In: Wyllie E, editor. The Treatment of Epilepsy: Principles and Practice. Philadelphia:Lea and Febiger, 1993:552–570.
  42. Smith SJM. Eyelid myoclonia with absences in adults: comparison with other absence seizures. In: Duncan JS, Panayiotopoulos CP, editors. Eyelid Myoclonia with Absences. London:Libbey, 1996:49–56.
  43. Tassinari CA, Michelucci R, Rubboli G, Passarelli D, Riguzzi P, Parmaggiani L, Volpi L, Bureau M. Myoclonic absence epilepsy. In: Duncan JS, Panayiotopoulos CP, editors. Typical Absences and Related Epileptic Syndromes. London:Churchill Communications Europe 1995:187–193.
  44. Timmings PL, Richens A. Efficacy of lamotrigine as monotherapy for juvenile myoclonic epilepsy: pilot study results. Epilepsia. 1993;34(Suppl 2):S160
  45. Wallace SJ. Lamotrigine in resistant childhood epilepsy. Neuropediatrics. 1989;20:116
  46. Yuen AWC, Rafter JEW. Lamotrigine (Lamictal) as add-on therapy in pediatric patients with treatment-resistant epilepsy: an overview. Epilepsia. 1992;33(Suppl 3):S82–83

PII: S0920-1211(97)00080-6

Epilepsy Research
Volume 29, Issue 2 , Pages 147-154 , January 1998

Article Tools